Table 6 Incidence of post-treatment Lyme disease syndrome (PTLDS) using different inclusion or outcome criteria, HUMTICK study, Belgium, 2016–2020
EM patients | DISS patients | |||
|---|---|---|---|---|
PTLDSa/N | Proportion (95% CI) | PTLDSa/N | Proportion (95% CI) | |
Baseline | 6.4/108 | 5.9 (2.7–12.9) | 3.15/15 | 20.9 (6.8–64.4) |
1: Possible cases included | 6.4/113 | 5.6 (2.6–12.3) | 4.15/18 | 23.0 (9.0–58.8) |
2: Insufficiently treated excludedb | 5.4/104 | 5.2 (2.2–12.2) | 3.15/14 | 22.4 (7.3–69.0) |
3: No standardized questionnaires | 9.45/108 | 8.7 (4.7–16.4) | 3.25/15 | 21.5 (7.0–66.0) |
4: No imputation | 6/105 | 5.7 (2.6–12.4) | 3/13 | 23.1 (8.6–62.3) |